2015 | Hydroxylated 2,4-diphenyl indenopyridine derivatives as a selective non-intercalative topoisomerase II alpha catalytic inhibitor | 권영주 | Article |
2015 | Modified 2,4-diaryl-5H-indeno[1,2-b]pyridines with hydroxyl and chlorine moiety: Synthesis, anticancer activity, and structure-activity relationship study | 권영주 | Article |
2017 | Novel 2-aryl-4-(4 '-hydroxypheny1)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors | 권영주 | Article |
2016 | Recent advances in anticancer chemotherapeutics based upon azepine scaffold | 창동신 | Review |
2016 | Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors | 권영주; 전규연 | Article |
2018 | Synthesis and SAR study of new hydroxy and chloro-substituted 2,4-diphenyl 5H-chromeno[4,3-b]pyridines as selective topoisomerase IIα-targeting anticancer agents | 권영주 | Article |
2015 | Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines | 권영주 | Article |
2015 | Topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines | 권영주 | Article |
2022 | Topoisomerase IIα inhibitory and antiproliferative activity of dihydroxylated 2,6-diphenyl-4-fluorophenylpyridines: Design, synthesis, and structure-activity relationships | 권영주; 황수연 | Article |